An Innovative Company Driven by R&D Pipeline and Platform

Createrna is an innovative drug research and development company in the clinical stage. Adhering to the dual-driven strategy of simultaneous development of the R&D pipeline and platform, the company has built a new drug research and development system covering the whole process from proof-of-concept, candidate compound screening, preclinical druggability development to clinical research.

  • 360+

    Employee

  • 280+

    Researchers

  • 15+

    Projects

  • 25+

    Pipelines

  • 200+

    Patents

  • 300+

    Partners

d1img01.jpg

The Global Distribution

  • d1svg1.svg

    Wuhan R&D Center

    Wuhan, China Wuhan High-tech Zone National biological Industry Base

    The integrated center for functional operations management and preclinical research and development. There are project management department, pharmaceutical department, Pharmacology Department and intellectual Property Department, which provide research and development services include POC, in vitro and in vivo model construction and drug synthesis for clinical projects.

  • d1svg2.svg

    Translational Medicine Center

    Wuhan, China Wuhan High-tech Zone National biological Industry Base

    Responsible for exploring clinical needs by integrating external expert resources, determining the relationship between targets and disease development, exploring and verifying the mechanism of action of drugs, discovering and selecting biomarkers, exploring product differentiation advantages, participating in the evaluation of clinical research strategies, and helping to improve the efficiency and success rate of new drug research and development.

  • 14725.svg

    Clinical Medical Center

    New Changjiang Plaza, 2 Youyi Avenue, Wuchang District, Wuhan City, China

    Led the company's clinical trials of innovative drugs, and was responsible for the clinical safety and efficacy studies, clinical pharmacology studies, compliance management of trial execution, clinical transfer and CRO, and construction of clinical base resources from before and after IND to market.

  • 01-314.svg

    Shanghai R&D Center

    Building A, 3333 Shenjiang Road, Pudong New Area, Shanghai, China

    The R&D branch center consists of project management department, pharmacy department, Pharmacology Department and Intellectual Property Department, which is responsible for providing R&D services such as proof of concept, in vitro and in vivo model construction and drug synthesis for clinical projects.

  • 02.svg

    International Center

    Maryland, USA

    Business development and FDA application for customers and investors of pharmaceutical companies in the United States and Europe, connecting research centers of the company with foreign pharmaceutical companies and scientific research institutions.

d1bg03.png

Development Course

  • In May 2013

    Createrna founded

  • In March 2015

    Submitted first Investigational New Drug (IND) application

  • In August 2018

    Established a pharmaceutical information platform focused on novel target drug discovery

  • In March 2022

    Founded the Clinical Medicine Center

  • In June 2023

    Completed Series A financing and established the Translational Medicine Center

  • In June 2026

    First novel drug,Lanoracopan Hydrochloride Tablets (Brand Name: Yishining®) received marketing approval from the National Medical Products Administration (NMPA) 

  • 2013

  • 2017

  • 2018

  • 2022

  • 2023

  • 2026

Honors and Qualifications

  • National High-Tech Enterprise

  • National Torch Plan Key High-Tech Enterprise

  • National Postdoctoral Research Station

  • National and Local Joint Engineering Research Center

Partners

  • d1logo.png
    5.1.png
  • 5.2.png
    5.3.png
  • 5.4.png
    5.5.png
  • 5.6.png
    5.7.png